# Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects

> **NCT01364441** · PHASE1 · COMPLETED · sponsor: **Ono Pharma USA Inc** · enrollment: 48 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** ONO-2952
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01364441
- **Lead sponsor:** Ono Pharma USA Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-08
- **Final completion:** —
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364441, "Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01364441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*